ANAB Next Earnings Date Notes

— AnaptysBio (ticker: ANAB) is a clinical-stage biotechnology company focused on the discovery & development of novel antibody-based therapies for inflammation & immunological diseases. The company leverages its proprietary somatic hypermutation platform to develop differentiated monoclonal antibodies, including candidates targeting diseases like chronic urticaria & atopic dermatitis, alongside a royalty-earning partnership pipeline. As you prepare for the next ANAB earnings call, key business metrics to monitor include clinical progress of lead assets (notably ROSnilimab & ANB032)—with updates on enrollment & pivotal study timelines—R&D expenses, and cash runway, given the company's pre-commercial stage. Additionally, keep tabs on milestones and potential partnership revenues, as AnaptysBio often relies on upfront payments, milestone payments, & potential royalties from collaborations. Pipeline advancement—both in-house developments and partnered programs—and clarity on regulatory guidance or trial readouts, are critical for assessing long-term success. Finally, management's commentary on strategic priorities, cost management, & future clinical catalysts should provide insight into ANAB's ability to sustain innovation and value creation in the highly competitive immunology sector. The next projected earnings date for ANAB is 9/22/2026 after close (stay tuned for a confirmed earnings date once announced).

ANAB Next Earnings Date FAQ

On this page we presented the ANAB Next Earnings Date information for AnaptysBio along with recent past earnings dates. For Q1 of 2026, ANAB reported earnings of -1.840/share, with the earnings report taking place on 5/12/2026. For Q4 of 2025, ANAB reported earnings of 1.580/share, with the earnings report taking place on 3/3/2026. For Q3 of 2025, ANAB reported earnings of 0.520/share, with the earnings report taking place on 11/4/2025. For Q2 of 2025, ANAB reported earnings of -1.340/share, with the earnings report taking place on 8/6/2025. For Q1 of 2025, ANAB reported earnings of -1.280/share, with the earnings report taking place on 5/5/2025. Based on these past earnings dates, the projected next earnings date for ANAB is 9/22/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as AnaptysBio. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to AnaptysBio shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research AnaptysBio next earnings dates as well as any other stock out there in our coverage universe, to see when the next ANAB earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ANAB's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ANAB next earnings date.